Advanced search
Publication Cover
Leukemia & Lymphoma Volume 57, 2016 - Issue 1
Submit an article Journal homepage
362
Views
24
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Lymphoma in acquired generalized lipodystrophy

Rebecca J. BrownDiabetes, Endocrinology and Obesity Branch (DEOB), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD, USACorrespondence[email protected]
,
Jean L. ChanBristol Myers Squibb, San Diego, CA, USA
,
Elaine S. JaffeHematopathology Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA
,
Elaine CochranDiabetes, Endocrinology and Obesity Branch (DEOB), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD, USA
,
Alex M. DePaoliWilliam Sansum Diabetes Center, Santa Barbara, CA, USA
,
Jean-Francois GautierDepartment of Diabetes and Endocrinology, Assistance Publique – Hôpitaux de Paris, DHU FIRE, Lariboisière Hospital, University Paris-Diderot Paris-7, Paris, France
,
Cecile GoujardAPHP, Hôpital Bicêtre; Inserm CESP U1018; Faculté de Médecine Paris-Sud; Le Kremlin Bicêtre, Paris, France
,
Corinne VigourouxInserm, UMR_S938, Centre de Recherche Saint-Antoine, Faculté de Médecine Pierre et Marie Curie, F-75012Paris, France;Sorbonne Universités, UPMC Univ Paris 6, UMR S938, F-75005, Paris, France;ICAN, Institute of Cardiometabolism and Nutrition, F-75013, Paris, France;AP-HP, Hôpital Saint-Antoine, Laboratoire Commun de Biologie et Génétique Moléculaires, F-75012, Paris, France
&
Phillip GordenDiabetes, Endocrinology and Obesity Branch (DEOB), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD, USA
 show all
Pages 45-50 | Received 26 Feb 2015, Accepted 06 Apr 2015, Published online: 12 May 2015

References

  • Garg A. Clinical review. Lipodystrophies: genetic and acquired body fat disorders. J Clin Endocrinol Metab 2011;96:3313–3325.
  • Haque WA, Shimomura I, Matsuzawa Y, Garg A. Serum adiponectin and leptin levels in patients with lipodystrophies. J Clin Endocrinol Metab 2002;87:2395.
  • Chan JL, Lutz K, Cochran E, et al. Clinical effects of long-term metreleptin treatment in patients with lipodystrophy. Endocr Pract 2011;17:922–932.
  • Chong AY, Lupsa BC, Cochran EK, et al. Efficacy of leptin therapy in the different forms of human lipodystrophy. Diabetologia 2010;53: 27–35.
  • Oral EA, Simha V, Ruiz E, et al. Leptin-replacement therapy for lipodystrophy. N Engl J Med 2002;346:570–578.
  • Park JY, Javor ED, Cochran EK, et al. Long-term efficacy of leptin replacement in patients with Dunnigan-type familial partial lipodystrophy. Metabolism 2007;56:508–516.
  • Ebihara K, Kusakabe T, Hirata M, et al. Efficacy and safety of leptin-replacement therapy and possible mechanisms of leptin actions in patients with generalized lipodystrophy. J Clin Endocrinol Metab 2007;92:532–541.
  • Araujo-Vilar D, Sanchez-Iglesias S, Guillin-Amarelle C, et al. Recombinant human leptin treatment in genetic lipodystrophic syndromes: the long-term Spanish experience. Endocrine 2014; 49:139–147.
  • Aslam A, Savage DB, Coulson IH. Acquired generalized lipodystrophy associated with peripheral T cell lymphoma with cutaneous infiltration. Int J Dermatol 2013 Epub ahead of print.
  • Yiannias JA, DiCaudo DJ, Maskin E. Peripheral T-cell lymphoma presenting as lipoatrophy and nodules. Int J Dermatol 2006;45: 1415–1419.
  • Hall SW, Gillespie JJ, Tenczynski TF. Generalized lipodystrophy, scleroderma, and Hodgkin’s disease. Arch Intern Med 1978;138: 1303–1304.
  • Wang S, Vose J. Epidemiology and prognosis of T-cell lymphoma. In: Foss F, editor. T-cell lymphomas. New York: Humana Press; 2013. pp 25–39.
  • Garg A. Acquired and inherited lipodystrophies. N Engl J Med 2004;350:1220–1234.
  • Misra A, Garg A. Clinical features and metabolic derangements in acquired generalized lipodystrophy: case reports and review of the literature. Medicine (Baltimore) 2003;82:129–146.
  • Savage DB, Semple RK, Clatworthy MR, et al. Complement abnormalities in acquired lipodystrophy revisited. J Clin Endocrinol Metab 2009;94:10–16.
  • Bingham A, Mamyrova G, Rother KI, et al. Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity. Medicine (Baltimore) 2008;87:70–86.
  • Hubler A, Abendroth K, Keiner T, et al. Dysregulation of insulin-like growth factors in a case of generalized acquired lipoatrophic diabetes mellitus (Lawrence Syndrome) connected with autoantibodies against adipocyte membranes. Exp Clin Endocrinol Diabetes 1998;106:79–84.
  • Smedby KE, Askling J, Mariette X, Baecklund E. Autoimmune and inflammatory disorders and risk of malignant lymphomas – an update. J Intern Med 2008;264:514–527.
  • Ekstrom Smedby K, Vajdic CM, Falster M, et al. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood 2008;111:4029–4038.
  • Fallah M, Liu X, Ji J, et al. Autoimmune diseases associated with non-Hodgkin lymphoma: a nationwide cohort study. Ann Oncol 2014;25:2025–2030.
  • Kedar A, Braylan RC. Lymphohistiocytic anaplastic large cell lymphoma stage I: long-term survival after resection alone. Pediatr Hematol Oncol 2000;17:261–268.
  • Oschlies I, Lisfeld J, Lamant L, et al. ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study. Haematologica 2013;98:50–56.
  • Lord GM, Matarese G, Howard JK, et al. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998;394:897–901.
  • Ozata M, Ozdemir IC, Licinio J. Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. J Clin Endocrinol Metab 1999;84:3686–3695.
  • Oral EA, Javor ED, Ding L, et al. Leptin replacement therapy modulates circulating lymphocyte subsets and cytokine responsiveness in severe lipodystrophy. J Clin Endocrinol Metab 2006;91:621–628.
  • Endocrinologic and Metabolic Drugs Advisory Committee Briefing Document for metreleptin (BLA STN125390); 2013:29.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.